A study suggests that a reduced dose of enfortumab vedotin may lower toxicity in older patients with urothelial carcinoma, ...
Why I built thisIsn't it hard to find information on CDx?When working in a pathology laboratory, clinicians sometimes ask ...
Astellas Announced Presentation of 21 Abstracts at ESMO 2026 Including Prostate, Urothelial, GEJ, Lung and Pancreatic cancers ...
Bladder and Urothelial Cancer Trials to Watch at ESMO 2026 / bladder cancer, cancer, cancer care, Cancer research, cancer ...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that 21 abstracts from its oncology portfolio will be presented at the European Society for Medical ...
New research shows that BH3 mimetic drugs targeting antiapoptotic Bcl-2 family proteins can sensitize bladder cancer cells ...
MIAMI - Summit Therapeutics Inc. (Nasdaq: SMMT) today announced a clinical trial collaboration agreement with Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/NYSE: AZN) to evaluate ivonescimab, a ...
Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the successful closing of AstraZeneca’s (LSE/STO/NYSE: AZN) strategic equity investment in Summit. The equity investment will support continued ...
In Part 1, I wrote about how cancers of the urinary tract present with the sign of "painless, yet intermittent" hematuria, ...
Daiichi Sankyo (4568.TS) and AstraZeneca (AZN) have entered into a clinical trial collaboration agreement with Summit Therapeutics (SMMT) to evaluate Datroway (datopotamab deruxtecan) in combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results